170 related articles for article (PubMed ID: 17239234)
1. Improved single-chain transactivators of the Tet-On gene expression system.
Zhou X; Symons J; Hoppes R; Krueger C; Berens C; Hillen W; Berkhout B; Das AT
BMC Biotechnol; 2007 Jan; 7():6. PubMed ID: 17239234
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of tTS-H4: a novel transcriptional repressor that is compatible with the reverse tetracycline-controlled TET-ON system.
Bockamp E; Christel C; Hameyer D; Khobta A; Maringer M; Reis M; Heck R; Cabezas-Wallscheid N; Epe B; Oesch-Bartlomowicz B; Kaina B; Schmitt S; Eshkind L
J Gene Med; 2007 Apr; 9(4):308-18. PubMed ID: 17330923
[TBL] [Abstract][Full Text] [Related]
3. Optimization of the Tet-On system for regulated gene expression through viral evolution.
Zhou X; Vink M; Klaver B; Berkhout B; Das AT
Gene Ther; 2006 Oct; 13(19):1382-90. PubMed ID: 16724096
[TBL] [Abstract][Full Text] [Related]
4. Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter.
Markusic D; Oude-Elferink R; Das AT; Berkhout B; Seppen J
Nucleic Acids Res; 2005 Apr; 33(6):e63. PubMed ID: 15809225
[TBL] [Abstract][Full Text] [Related]
5. Engineered Tet repressors with recognition specificity for the tetO-4C5G operator variant.
Krueger M; Scholz O; Wisshak S; Hillen W
Gene; 2007 Dec; 404(1-2):93-100. PubMed ID: 17928170
[TBL] [Abstract][Full Text] [Related]
6. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells.
Freundlieb S; Schirra-Müller C; Bujard H
J Gene Med; 1999; 1(1):4-12. PubMed ID: 10738580
[TBL] [Abstract][Full Text] [Related]
7. Modification of the Tet-On regulatory system prevents the conditional-live HIV-1 variant from losing doxycycline-control.
Zhou X; Vink M; Berkhout B; Das AT
Retrovirology; 2006 Nov; 3():82. PubMed ID: 17094796
[TBL] [Abstract][Full Text] [Related]
8. Tight control of transcription in Toxoplasma gondii using an alternative tet repressor.
van Poppel NF; Welagen J; Duisters RF; Vermeulen AN; Schaap D
Int J Parasitol; 2006 Apr; 36(4):443-52. PubMed ID: 16516216
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary study on regulable DNA vaccines against Plasmodium falciparum].
Lei JC; Miao J; Li X; Schonig K; Bujard H; Xue CF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):356-9. PubMed ID: 15193238
[TBL] [Abstract][Full Text] [Related]
10. Controlled transgene expression by E1-E4-defective adenovirus vectors harbouring a "tet-on" switch system.
Fender P; Jeanson L; Ivanov MA; Colin P; Mallet J; Dedieu JF; Latta-Mahieu M
J Gene Med; 2002; 4(6):668-75. PubMed ID: 12439858
[TBL] [Abstract][Full Text] [Related]
11. Synthetic tetracycline-inducible regulatory networks: computer-aided design of dynamic phenotypes.
Sotiropoulos V; Kaznessis YN
BMC Syst Biol; 2007 Jan; 1():7. PubMed ID: 17408514
[TBL] [Abstract][Full Text] [Related]
12. Optimization and direct comparison of the dimerizer and reverse tet transcriptional control systems.
Go WY; Ho SN
J Gene Med; 2002; 4(3):258-70. PubMed ID: 12112643
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline- and tetracycline-regulated transcriptional silencer enhance the expression level and transactivating performance of rtTA.
Lai JF; Cheng HY; Cheng TL; Lin YY; Chen LC; Lin MT; Jou TS
J Gene Med; 2004 Dec; 6(12):1403-13. PubMed ID: 15523716
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamic analysis of tetracycline-mediated induction of Tet repressor by a quantitative methylation protection assay.
Lederer T; Takahashi M; Hillen W
Anal Biochem; 1995 Dec; 232(2):190-6. PubMed ID: 8747474
[TBL] [Abstract][Full Text] [Related]
15. hCMV and Tet promoters for inducible gene expression in rat neurons in vitro and in vivo.
Konopka W; Duniec K; Mioduszewska B; Proszynski T; Jaworski J; Kaczmarek L
Neurobiol Dis; 2005; 19(1-2):283-92. PubMed ID: 15837584
[TBL] [Abstract][Full Text] [Related]
16. Inducibility of doxycycline-regulated gene in neural and neuroendocrine cells strongly depends on the appropriate choice of a tetracycline-responsive promoter.
Klopotowska D; Strzadala L; Matuszyk J
Neurochem Int; 2008 Jan; 52(1-2):221-9. PubMed ID: 17618706
[TBL] [Abstract][Full Text] [Related]
17. Transactivator mutants with altered effector specificity allow selective regulation of two genes by tetracycline variants.
Krueger C; Schmidt A; Danke C; Hillen W; Berens C
Gene; 2004 Apr; 331():125-31. PubMed ID: 15094198
[TBL] [Abstract][Full Text] [Related]
18. Tight regulation of transgene expression by tetracycline-dependent activator and repressor in brain.
Uchida S; Sakai S; Furuichi T; Hosoda H; Toyota K; Ishii T; Kitamoto A; Sekine M; Koike K; Masushige S; Murphy G; Silva AJ; Kida S
Genes Brain Behav; 2006 Feb; 5(1):96-106. PubMed ID: 16436193
[TBL] [Abstract][Full Text] [Related]
19. Characterization of tetracycline-inducible bitransgenic Krt12rtTA/+/tet-O-LacZ mice.
Chikama T; Hayashi Y; Liu CY; Terai N; Terai K; Kao CW; Wang L; Hayashi M; Nishida T; Sanford P; Doestchman T; Kao WW
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1966-72. PubMed ID: 15914610
[TBL] [Abstract][Full Text] [Related]
20. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity.
Urlinger S; Baron U; Thellmann M; Hasan MT; Bujard H; Hillen W
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7963-8. PubMed ID: 10859354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
